Ticker > Company >

Mukka Proteins share price

Mukka Proteins Ltd.

NSE: MUKKA BSE: 544135 SECTOR: Animal Feed  90.95 K   132   22

27.80
+0.24 (0.87%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 27.95

Today's Low

₹ 26.8

52 Week High

₹ 47.94

52 Week Low

₹ 25.49

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

834 Cr.

Enterprise Value

1209.88 Cr.

No. of Shares

30 Cr.

P/E

20.46

P/B

2.05

Face Value

₹ 1

Div. Yield

0 %

Book Value (TTM)

₹  13.53

CASH

39.21 Cr.

DEBT

415.09 Cr.

Promoter Holding

73.33 %

EPS (TTM)

₹  1.36

Sales Growth

-30.1%

ROE

10.83 %

ROCE

11.49%

Profit Growth

-33.58 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-30.1%
3 Year8.57%
5 Year10.2%

Profit Growth

1 Year-33.58%
3 Year28.12%
5 Year26.56%

ROE%

1 Year10.83%
3 Year25.09%
5 Year22.05%

ROCE %

1 Year11.49%
3 Year17.78%
5 Year15.5%

Debt/Equity

1.0265

Price to Cash Flow

-6.3

Interest Cover Ratio

2.5318

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 73.33 0.00
Mar 2025 73.33 0.00
Dec 2024 73.33 0.00
Sep 2024 73.33 0.00
Jun 2024 73.33 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 28.1182906278637% for the Past 3 years.
  • Company has been maintaining healthy ROE of 25.0933333333333% over the past 3 years.
  • The company has a high promoter holding of 73.33%.

 Limitations

  • The company has shown a poor revenue growth of 8.57039755680442% for the Past 3 years.
  • Company has contingent liabilities of 156.448 Cr.
  • Company has negative cash flow from operations of -132.375.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 148.42 126.09 286.94 325.3 135.79
Total Expenditure 139.36 118.95 250.28 302.03 125.13
Operating Profit 9.06 7.14 36.66 23.27 10.66
Other Income 3.06 2.92 6.23 4.26 3.32
Interest 7.43 7.86 10.12 8.91 10.35
Depreciation 1.53 1.59 1.38 1.36 1.36
Exceptional Items 0 0 0 0 0
Profit Before Tax 3.16 0.6 31.39 17.26 2.27
Tax 0.81 -0.47 6.59 3.97 0.66
Profit After Tax 2.35 1.07 24.8 13.29 1.61
Adjusted EPS (Rs) 0.08 0.04 0.83 0.44 0.05

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 536.25 692.89 1066.4 1268.54 886.74
Total Expenditure 529.39 660.37 1000.73 1187.16 810.63
Operating Profit 6.86 32.52 65.67 81.39 76.12
Other Income 9.15 7.74 8.87 16.87 16.48
Interest 6.95 8.35 15.18 24.19 34.33
Depreciation 3 3.72 4.27 5.62 5.86
Exceptional Items 0 0 0 0 0
Profit Before Tax 6.06 28.2 55.1 71.65 52.58
Tax 1.45 8.38 15.67 8.89 10.9
Net Profit 4.61 19.82 39.42 62.76 41.68
Adjusted EPS (Rs.) 0.21 0.9 1.79 2.09 1.39

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 5.5 22 22 30 30
Total Reserves 57.36 60.29 99.64 335.17 374.37
Borrowings 6.96 3.04 0.27 3.32 1.29
Other N/C liabilities 3.51 6.25 9.46 7.4 6.56
Current liabilities 215.05 237.5 368.67 475.24 561.79
Total Liabilities 288.38 329.07 500.03 851.13 973.99
Assets
Net Block 47.59 48.3 51.08 58.46 58.24
Capital WIP 0 0 0 0 3.8
Intangible WIP 0 0 0 0 0
Investments 11.53 20.67 23.63 34.38 43.8
Loans & Advances 2.02 1.97 3.33 7.11 10.35
Other N/C Assets 1.42 1.38 1.59 1.48 1.38
Current Assets 225.82 256.75 420.4 749.71 856.42
Total Assets 288.38 329.07 500.03 851.13 973.99
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 6.06 28.2 55.1 71.65 52.58
Adjustment 3.63 5.05 7.71 14.98 22.42
Changes in Assets & Liabilities -7.74 -46.21 -101.08 -205.29 -204.75
Tax Paid -4.29 -2.34 -8.68 -22.58 -2.62
Operating Cash Flow -2.33 -15.3 -46.96 -141.24 -132.38
Investing Cash Flow -5.41 -7.25 0.71 -46.25 -18.02
Financing Cash Flow 8.06 27.25 61.12 258.05 59.65
Net Cash Flow 0.31 4.7 14.87 70.57 -90.74

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 73.33 73.33 73.33 73.33 73.33
k mohammad arif 16.13 16.13 16.13 16.13 16.13
k mohammed althaf 16.13 16.13 16.13 16.13 16.13
kalandan abdul razak 7.33 7.33 7.33 7.33 7.33
mohammed haris k 30.23 30.23 30.23 30.23 30.23
umaiyya banu 3.50 3.50 3.50 3.50 3.50
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 26.67 26.67 26.67 26.67 26.67
craft emerging market fun... 1.19 1.19 1.19 1.19 1.19
llp 0.02 0.04 0.05 0.05 0.03
neomile growth fund - ser... 2.48 1.98 1.98 1.98 1.87
multitude growth funds li... - - 1.12 1.12 -
neomile corporate advisor... - 1.02 1.02 - -
elara india opportunities... 1.20 - - - -
eminence global fund pcc-... 1.31 - - - -

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit and Research reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation and Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Mukka Proteins informs about updates on acquisition 2 Sep, 1:05 PM Mukka Proteins completes acquisition of 51% stake in FABBCO 2 Sep, 12:17 PM Mukka Proteins empanelled as Authorised Waste Processor by BSWML 14 Aug, 3:58 PM Mukka Proteins - Quaterly Results 13 Aug, 6:51 PM Mukka Proteins - Quaterly Results 13 Aug, 6:51 PM Mukka Proteins gets nod to acquire 51% stake in Mukka Frozen Impex 28 Jul, 11:43 AM Mukka Proteins gets nod to acquire 70% paid-up share capital in Mukka Proteins Vietnam 28 Jul, 10:30 AM Mukka Proteins informs about newspaper publication 17 May, 12:32 PM Mukka Proteins gets nod for further acquisition of shares in Ocean Proteins 16 May, 11:30 AM Mukka Proteins - Quaterly Results 15 May, 6:25 PM Mukka Proteins - Quaterly Results 15 May, 6:25 PM Mukka Proteins - Quaterly Results 15 May, 6:25 PM Mukka Proteins completes acquisition of 51% stake in GSM Marine Export 22 Apr, 10:21 AM Mukka Proteins gets nod to make strategic investment in FABBCO 27 Mar, 4:58 PM Mukka Proteins gets nod to make strategic investment in GSM Marine Export 26 Mar, 10:00 AM Mukka Proteins receives purchase orders worth Rs 44.28 crore 6 Mar, 9:49 AM Mukka Proteins - Quaterly Results 14 Feb, 6:34 PM Mukka Proteins - Quaterly Results 14 Feb, 6:34 PM Mukka Proteins informs about updates 8 Jan, 2:28 PM Mukka Proteins informs about closure of trading window 28 Dec, 12:25 PM Mukka Proteins completes disinvestment of entire stake in MSFI (Bangladesh) 17 Dec, 5:45 PM Mukka Proteins informs about press release 16 Nov, 4:26 PM Mukka Proteins informs about newspaper advertisement 16 Nov, 11:20 AM Mukka Proteins - Quaterly Results 13 Aug, 1:28 PM Mukka Proteins - Quaterly Results 14 May, 12:42 PM Mukka Proteins - Quaterly Results 14 May, 12:42 PM Mukka Proteins - Quaterly Results 14 May, 12:42 PM Mukka Proteins bags purchase orders worth Rs 50.39 crore 1 Apr, 2:59 PM Mukka Proteins - Quaterly Results 28 Mar, 12:14 PM Mukka Proteins - Quaterly Results 28 Mar, 12:14 PM Mukka Proteins - Quaterly Results 28 Mar, 12:14 PM Mukka Proteins bags purchase order worth Rs 15.25 crore 14 Mar, 6:17 PM Mukka Proteins coming with an IPO to raise Rs 224 crore 28 Feb, 12:01 PM Mukka Proteins gets SEBI’s go-ahead to raise funds via IPO 8 Nov, 12:03 PM Mukka Proteins refiles DRHP with SEBI 19 Jun, 2:18 PM

Mukka Proteins Stock Price Analysis and Quick Research Report. Is Mukka Proteins an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Mukka Proteins. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Mukka Proteins has a PE ratio of 20.3399808668776 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Mukka Proteins has ROA of 4.5677% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Mukka Proteins has a Current ratio of 1.5245.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Mukka Proteins has a ROE of 10.8332%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Mukka Proteins has a Debt to Equity ratio of 1.0265 which means that the company has low proportion of debt in its capital.

  • Sales growth: Mukka Proteins has reported revenue growth of -30.0975% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Mukka Proteins for the current financial year is 8.58388507154836%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Mukka Proteins is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Mukka Proteins is Rs 1.3589. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Mukka Proteins in Ticker for free. Also, one can get the intrinsic value of Mukka Proteins by using Valuation Calculators, which are available with a Finology ONE subscription. 

Mukka Proteins FAQs

Q1. What is Mukka Proteins share price today?
Ans: The current share price of Mukka Proteins is Rs 27.64.

Q2. What is the market capitalisation of Mukka Proteins?
Ans: Mukka Proteins has a market capitalisation of Rs 829.2 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Mukka Proteins?
Ans: The PE ratio of Mukka Proteins is 20.3399808668776 and the P/B ratio of Mukka Proteins is 2.0424752080162, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Mukka Proteins share?
Ans: The 52-week high share price of Mukka Proteins is Rs 47.39, and the 52-week low share price of Mukka Proteins is Rs 24.75.

Q5. Does Mukka Proteins pay dividends?
Ans: Currently, Mukka Proteins does not pay dividends. Dividend yield of Mukka Proteins is around 0%.

Q6. What are the face value and book value of Mukka Proteins shares?
Ans: The face value of Mukka Proteins shares is Rs 1, while the book value per share of Mukka Proteins is around Rs 13.5326. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Mukka Proteins?
Ans: Mukka Proteins has a total debt of Rs 415.087 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Mukka Proteins?
Ans: The ROE of Mukka Proteins is 10.8332% and ROCE of Mukka Proteins is 11.4921%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Mukka Proteins a good buy for the long term?
Ans: The Mukka Proteins long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Mukka Proteins undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Mukka Proteins appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Mukka Proteins’s financials?
Ans: You can review Mukka Proteins’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Mukka Proteins
X